472 related articles for article (PubMed ID: 26575138)
1. Treatment Options for Statin-Associated Muscle Symptoms.
Laufs U; Scharnagl H; Halle M; Windler E; Endres M; März W
Dtsch Arztebl Int; 2015 Oct; 112(44):748-55. PubMed ID: 26575138
[TBL] [Abstract][Full Text] [Related]
2. Statin intolerance.
Laufs U; Scharnagl H; März W
Curr Opin Lipidol; 2015 Dec; 26(6):492-501. PubMed ID: 26780003
[TBL] [Abstract][Full Text] [Related]
3. Suggested clinical approach for the diagnosis and management of 'statin intolerance' with an emphasis on muscle-related side-effects.
Sivashanmugarajah A; Fulcher J; Sullivan D; Elam M; Jenkins A; Keech A
Intern Med J; 2019 Sep; 49(9):1081-1091. PubMed ID: 31507054
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment.
Chatzizisis YS; Koskinas KC; Misirli G; Vaklavas C; Hatzitolios A; Giannoglou GD
Drug Saf; 2010 Mar; 33(3):171-87. PubMed ID: 20158283
[TBL] [Abstract][Full Text] [Related]
5. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
Stroes ES; Thompson PD; Corsini A; Vladutiu GD; Raal FJ; Ray KK; Roden M; Stein E; Tokgözoğlu L; Nordestgaard BG; Bruckert E; De Backer G; Krauss RM; Laufs U; Santos RD; Hegele RA; Hovingh GK; Leiter LA; Mach F; März W; Newman CB; Wiklund O; Jacobson TA; Catapano AL; Chapman MJ; Ginsberg HN;
Eur Heart J; 2015 May; 36(17):1012-22. PubMed ID: 25694464
[TBL] [Abstract][Full Text] [Related]
6. An overview of statin-induced myopathy and perspectives for the future.
Nikolic D; Banach M; Chianetta R; Luzzu LM; Pantea Stoian A; Diaconu CC; Citarrella R; Montalto G; Rizzo M
Expert Opin Drug Saf; 2020 May; 19(5):601-615. PubMed ID: 32233708
[No Abstract] [Full Text] [Related]
7. Statin-Associated Muscle Disease: Advances in Diagnosis and Management.
Taylor BA; Thompson PD
Neurotherapeutics; 2018 Oct; 15(4):1006-1017. PubMed ID: 30251222
[TBL] [Abstract][Full Text] [Related]
8. Statin-associated myopathy.
Thompson PD; Clarkson P; Karas RH
JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
[TBL] [Abstract][Full Text] [Related]
9. Statin safety: an overview and assessment of the data--2005.
Bays H
Am J Cardiol; 2006 Apr; 97(8A):6C-26C. PubMed ID: 16581330
[TBL] [Abstract][Full Text] [Related]
10. Management Strategies for Statin-Associated Muscle Symptoms: How Useful Is Same-Statin Rechallenge?
Brennan ET; Joy TR
Can J Cardiol; 2017 May; 33(5):666-673. PubMed ID: 28449837
[TBL] [Abstract][Full Text] [Related]
11. Overcoming toxicity and side-effects of lipid-lowering therapies.
Wilkinson MJ; Laffin LJ; Davidson MH
Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):439-52. PubMed ID: 24840269
[TBL] [Abstract][Full Text] [Related]
12. [Statin intolerance and statin-associated muscular pain].
Stürzebecher PE; Schumann F; Kassner U; Laufs U
Herz; 2022 Jun; 47(3):204-211. PubMed ID: 35451596
[TBL] [Abstract][Full Text] [Related]
13. Practical aspects in the management of statin-associated muscle symptoms (SAMS).
Laufs U; Filipiak KJ; Gouni-Berthold I; Catapano AL;
Atheroscler Suppl; 2017 Apr; 26():45-55. PubMed ID: 28434484
[TBL] [Abstract][Full Text] [Related]
14. Optimizing Cholesterol Treatment in Patients With Muscle Complaints.
Rosenson RS; Baker S; Banach M; Borow KM; Braun LT; Bruckert E; Brunham LR; Catapano AL; Elam MB; Mancini GBJ; Moriarty PM; Morris PB; Muntner P; Ray KK; Stroes ES; Taylor BA; Taylor VH; Watts GF; Thompson PD
J Am Coll Cardiol; 2017 Sep; 70(10):1290-1301. PubMed ID: 28859793
[TBL] [Abstract][Full Text] [Related]
15. Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study.
Cho L; Rocco M; Colquhoun D; Sullivan D; Rosenson RS; Dent R; Xue A; Scott R; Wasserman SM; Stroes E
Cardiovasc Drugs Ther; 2016 Jun; 30(3):297-304. PubMed ID: 26936841
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of statin-associated skeletal muscle-associated symptoms.
Bouitbir J; Sanvee GM; Panajatovic MV; Singh F; Krähenbühl S
Pharmacol Res; 2020 Apr; 154():104201. PubMed ID: 30877064
[TBL] [Abstract][Full Text] [Related]
17. Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy.
Vinci P; Panizon E; Tosoni LM; Cerrato C; Pellicori F; Mearelli F; Biasinutto C; Fiotti N; Di Girolamo FG; Biolo G
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769118
[TBL] [Abstract][Full Text] [Related]
18. Statin-associated myopathy.
Hamilton-Craig I
Med J Aust; 2001 Nov; 175(9):486-9. PubMed ID: 11758079
[TBL] [Abstract][Full Text] [Related]
19. Statin associated muscle symptoms (SAMS): strategies for prevention, assessment and management.
Iatan I; Mancini GBJ; Yeoh E; Hegele RA
Expert Rev Cardiovasc Ther; 2023 Jun; 21(6):423-435. PubMed ID: 37212306
[TBL] [Abstract][Full Text] [Related]
20. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.
Brunham LR; Baker S; Mammen A; Mancini GBJ; Rosenson RS
Cardiovasc Res; 2018 Jul; 114(8):1073-1081. PubMed ID: 29878063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
